NKTX (STOCKS)
Nkarta, Inc. Common Stock
$1.970000
-0.030000 (-1.50%)
Prev close: $2.000000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Paul J. Hastings
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $139.57M
- Employees
- 157
- P/E (TTM)
- -1.42
- P/B (TTM)
- 0.40
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
4
Strong Buy
7
Buy
2
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2025 (Q3)
|
$-0.29 | $-0.32 | +0.0296 | +9.26% |
|
Jun 2025 (Q2)
|
$-0.31 | $-0.36 | +0.0521 | +14.39% |
|
Mar 2025 (Q1)
|
$-0.43 | $-0.45 | +0.0188 | +4.19% |
|
Dec 2024 (Q4)
|
$-0.35 | $-0.42 | +0.0711 | +16.88% |
Financial Statements
| Revenues | $0.00 |
| Nonoperating Income/Loss | $19.35M |
| Operating Expenses | $121.96M |
| Depreciation and Amortization | $9.22M |
| Research and Development | $88.28M |
| Other Operating Expenses | $24.46M |
| Operating Income/Loss | -$121.96M |
| Income/Loss From Continuing Operations After Tax | -$102.61M |
| Income/Loss From Continuing Operations Before Tax | -$102.61M |
| Income Tax Expense/Benefit | $0.00 |
| Net Income/Loss | -$102.61M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$102.61M |
| Net Income/Loss Available To Common Stockholders, Basic | -$102.61M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$1.37 |
| Diluted Earnings Per Share | -$1.37 |
| Basic Average Shares | 223,842,613 |
| Diluted Average Shares | 223,842,613 |
| Assets | $427.24M |
| Current Assets | $289.28M |
| Noncurrent Assets | $137.96M |
| Fixed Assets | $68.18M |
| Other Non-current Assets | $69.78M |
| Liabilities | $89.34M |
| Current Liabilities | $18.99M |
| Accounts Payable | $1.44M |
| Wages | $5.68M |
| Other Current Liabilities | $11.88M |
| Noncurrent Liabilities | $70.35M |
| Equity | $337.90M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $337.90M |
| Liabilities And Equity | $427.24M |
| Net Cash Flow From Operating Activities | -$91.80M |
| Net Cash Flow From Operating Activities, Continuing | -$91.80M |
| Net Cash Flow From Investing Activities | $94.70M |
| Net Cash Flow From Investing Activities, Continuing | $94.70M |
| Net Cash Flow From Financing Activities | $261.00K |
| Net Cash Flow From Financing Activities, Continuing | $261.00K |
| Net Cash Flow | $3.15M |
| Net Cash Flow, Continuing | $3.15M |
| Comprehensive Income/Loss | -$103.48M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$103.79M |
| Other Comprehensive Income/Loss | -$22.58M |